Nasal Povidone-Iodine Solutions Effectively Inactivate SARS-CoV-2 In Vitro
Nasal povidone-iodine solutions at concentrations between 0.5% and 2.5% were capable of rapidly inactivating SARS-CoV-2 in vitro at relatively short contact times.
Home
CPAP Therapy Does Not Appear to Improve Nonalcoholic Fatty Liver Disease in OSA
The use of CPAP alone does not appear to improve hepatic steatosis and fibrosis in patients with nonalcoholic fatty liver disease and obstructive sleep apnea.
Ivacaftor Approval Expanded to Include Younger Patients With Cystic Fibrosis
The approval was based on data from a phase 3 open-label safety study that included a cohort of 6 children 4 months to <6 months of age.
Point-of-Care COVID-19 Antibody Test Gets Emergency Use Authorization
The reissued EUA allows for fingerstick blood samples to be tested in point-of-care settings.
Cefiderocol Approved for Hospital-Acquired, Ventilator-Associated Bacterial Pneumonia
The FDA has approved Fetroja® (cefiderocol; Shionogi) for the treatment of adult patients with HABP/VABP caused by susceptible Gram-negative pathogens.
Chinese Company Says Its COVID-19 Vaccine Should Be Available in U.S. in Early 2021
A Chinese pharmaceutical company claims its COVID-19 vaccine should available by early next year for distribution in the United States and other countries.
Occupational Eosinophlic Bronchitis in Individuals Exposed to Workplace Sensitizing Agents
Individuals exposed to workplace sensitizing agents may develop an isolated sputum eosinophilic response consistent with occupational eosinophilic bronchitis, even in the absence of asthma symptoms.
Trials Testing Convalescent Plasma for COVID-19 Expanded
Both randomized, placebo-controlled trials are expected to enroll approximately 1000 hospitalized patients.
ATS Issues Recommendations for Noninvasive Ventilation in COPD
The American Thoracic Society presented recommendations for the use of noninvasive ventilation in patients with COPD and chronic hypercapnia.
Nosocomial Spread of COVID-19 Minimal With Rigorous Infection Control Measures
Findings from a study published in JAMA Network Open suggest that rigorous infection control measures may be associated with minimized risk and provide reassurance to patients concerned about contracting COVID-19 in hospitals.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Lung Infection
